These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32982949)

  • 1. Corrigendum: Translation, Cultural Adaptation, and Validation of the Hiligaynon Montreal Cognitive Assessment Tool (MoCA-Hil) Among Patients With X-Linked Dystonia Parkinsonism (XDP).
    Aliling NB; Rivera AS; Jamora RDG
    Front Neurol; 2020; 11():947. PubMed ID: 32982949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation, Cultural Adaptation, and Validation of the Hiligaynon Montreal Cognitive Assessment Tool (MoCA-Hil) Among Patients With X-Linked Dystonia Parkinsonism (XDP).
    Aliling NB; Rivera AS; Jamora RDG
    Front Neurol; 2019; 10():1249. PubMed ID: 31849816
    [No Abstract]   [Full Text] [Related]  

  • 3. A Cross-Cultural Validation of the Filipino and Hiligaynon Versions of the Parts IIIB (Non-Motor Features) and IV (Activities of Daily Living) of the X-Linked Dystonia-Parkinsonism- MDSP Rating Scale.
    Santiano RAS; Rosales RL
    Clin Park Relat Disord; 2021; 5():100100. PubMed ID: 34988424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Validation of a Questionnaire for Distinguishing X-Linked Dystonia Parkinsonism From Its Mimics.
    Diestro JDB; Ang MAC; Mondia MWL; Pasco PMD
    Front Neurol; 2018; 9():991. PubMed ID: 30519214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism.
    Pasco PMD; Jamora RDG; Rosales RL; Diesta CCE; Ng AR; Teleg RA; Go CL; Lee L; Fernandez HH
    NPJ Parkinsons Dis; 2017; 3():24. PubMed ID: 28761929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).
    Kawarai T; Morigaki R; Kaji R; Goto S
    Brain Sci; 2017 Jun; 7(7):. PubMed ID: 28672841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing guidelines for the translation and cultural adaptation of the Montreal Cognitive Assessment: scoping review and qualitative synthesis.
    Khan G; Mirza N; Waheed W
    BJPsych Open; 2022 Jan; 8(1):e21. PubMed ID: 34991771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive profile of patients with X-linked dystonia-parkinsonism.
    Jamora RDG; Suratos CTR; Bautista JEC; Ramiro GMI; Westenberger A; Klein C; Ledesma LK
    J Neural Transm (Vienna); 2021 May; 128(5):671-678. PubMed ID: 33638704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and molecular analyses of X-linked dystonia-parkinsonism ("lubag") in women.
    Evidente VG; Nolte D; Niemann S; Advincula J; Mayo MC; Natividad FF; Müller U
    Arch Neurol; 2004 Dec; 61(12):1956-9. PubMed ID: 15596620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye movement deficits in X-linked dystonia-parkinsonism are related to striatal degeneration.
    Sprenger A; Hanssen H; Hagedorn I; Prasuhn J; Rosales RL; Jamora RDG; Diesta CC; Domingo A; Klein C; Brüggemann N; Helmchen C
    Parkinsonism Relat Disord; 2019 Apr; 61():170-178. PubMed ID: 30352750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of pallidal deep brain stimulation in X-linked dystonia parkinsonism (XDP): Up to 84 months follow-up and review of literature.
    Abejero JEE; Jamora RDG; Vesagas TS; Teleg RA; Rosales RL; Anlacan JP; Velasquez MS; Aguilar JA
    Parkinsonism Relat Disord; 2019 Mar; 60():81-86. PubMed ID: 30262378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Questionnaire for Distinguishing X-Linked Dystonia Parkinsonism From Its Mimics.
    Diestro JDB; Ang MAC; Mondia MWL; Pasco PMD
    Front Neurol; 2018; 9():830. PubMed ID: 30374324
    [No Abstract]   [Full Text] [Related]  

  • 13. The natural history of sex-linked recessive dystonia parkinsonism of Panay, Philippines (XDP).
    Lee LV; Maranon E; Demaisip C; Peralta O; Borres-Icasiano R; Arancillo J; Rivera C; Munoz E; Tan K; Reyes MT
    Parkinsonism Relat Disord; 2002 Oct; 9(1):29-38. PubMed ID: 12217620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
    Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
    Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.
    Tian R; Guo Y; Ye P; Zhang C; Luo Y
    PLoS One; 2020; 15(1):e0227073. PubMed ID: 31917792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonographic alteration of substantia nigra is related to parkinsonism-predominant course of X-linked dystonia-parkinsonism.
    Walter U; Rosales R; Rocco A; Westenberger A; Domingo A; Go CL; Brüggemann N; Klein C; Lee LV; Dressler D
    Parkinsonism Relat Disord; 2017 Apr; 37():43-49. PubMed ID: 28094105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia.
    Gil L; Ruiz de Sánchez C; Gil F; Romero SJ; Pretelt Burgos F
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):655-62. PubMed ID: 25320026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial Magnetic Resonance-Guided Focused Ultrasound in X-Linked Dystonia-Parkinsonism.
    Jamora RDG; Chang WC; Taira T
    Life (Basel); 2021 Apr; 11(5):. PubMed ID: 33925939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Cultural Applicability of the Montreal Cognitive Assessment (MoCA): A Systematic Review.
    O'Driscoll C; Shaikh M
    J Alzheimers Dis; 2017; 58(3):789-801. PubMed ID: 28482634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Analysis of the Different Treatment Modalities in X-Linked Dystonia-Parkinsonism.
    De Roxas RC; Jamora RDG
    Front Neurol; 2019; 10():500. PubMed ID: 31143158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.